[1]王要军, 孙自勤, 权启镇.参与肝纤维化的细胞因子[J].中国煤炭医学工业杂志, 2000, 3 (1) ∶4-6.
|
[2]Derek L, David C, Peter N.Insulin-like growth factors in healthand disease[J].Ann Intern Med, 1992, 16 (10) ∶854-857.
|
[3]Svegliati BG, Ridolti F, Disario A, et al.Insulin and insulin-likegrowth factor1 stimulate proliferation and typ1 collagen accumulationby human hepatic stellate cells:differential effects on sigal transduc-tion pathways[J].Hepatology, 1999, 29 (6) ∶1743-1751.
|
[4]Danaghy A, Ross R, Gimson A, et al.Growth hormone, Insulinlikegrowth factor, insulinlike growth factor binding proteins 1 and 3 inchronic liver disease[J].Hepatology, 1995, 21∶680-688.
|
[5]俞纯山.肝纤维化的检测及其临床意义[J].中华检测医学杂志, 2000, 23∶190-192.
|
[6]Saile B, DiRocc P, Dudas J, et al.IGF-1 induces DNA synthesisand apoptosis in rat liver hepatic stellate cells (HSC) but DNA syn-thesis and prolife ration in rat liver myofibroblasts[J].Lab Invest, 2004, 84 (8) ∶1037-1049.
|
[7]Disario A, Macarri G, Benedetti A.Intracellular PH regulation andNa/H exchange activity in human hepatic stellate cells:Effect ofplatelet-derived growth factor, insulin-like growth factor1 and in-sulin[J].J Hepatol, 2001, 34 (3) ∶378-385.
|
[8]蒋向荣, 陈治新, 张莉, 等.IGF-1在肝纤维化大鼠中的表达及IL-10的干预作用[J].中西医结合肝病杂志, 2003, 13 (3) ∶154-157.
|
[9]Zimmermann EB, Sartor RB, Mcall RD, et al.Insulinlike growthfactor 1 and interleukin1 beta messenger RNAin a rat model of gran-ulomatous enterocolitis and hepatitis[J].Gastroenterology, 1993, 105 (2) ∶399-403.
|
[1] | Yujie HUANG, Siyi FENG. Application value of two-dimensional shear wave elastography and serological models in the staging of liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2024, 40(3): 509-515. doi: 10.12449/JCH240312 |
[2] | Zhao Zhao, Qi WenQian, Zhao Ping. Research advances in insulin-like growth factor 1 receptor and its pathway in diagnosis and treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(4): 763-768. doi: 10.3969/j.issn.1001-5256.2017.04.038 |
[3] | Yan XiaoDi, Dong ZhiZhen, Chen Jie, Qiu LiWei, Wu Wei, Yao DengFu. Dynamic expression profile of the insulin-like growth factor-1 receptor during malignant transformation of hepatocytes[J]. Journal of Clinical Hepatology, 2013, 29(3): 217-222. |
[4] | Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198. |
[6] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[7] | Li ChunMing, Huang XiaoYun, Jin YueMing, Gong YuHua, Tan YouWen. Analysis of anti-fibrosis effect of combining lamivudine with captopril in 166 cases with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 102-105. |
[8] | Yu HongWei, Meng QingHua, Zhang FenYan, Li Juan, Wang JinHuan, Duan ZhongHui. Research on mechanism of hypoglycemia in Patients with Severe Chronic Hepatitis B.[J]. Journal of Clinical Hepatology, 2008, 24(3): 175-177. |
[9] | Xia Qi, Fu JieHai, Cai WeiMin, Liu RongHua. Diagnostic value of AST/PLT and GGT/PLT for hepatic fibrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 364-366. |
[17] | Kong Li, Li BingShun, Ren ZhongXuan, Hu YunLong, Liu JinXing. The study of inhibitory effect of IFN-α therapy for hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(6): 356-358. |
[20] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |